A systematic review of more than 2.3 million patients found that women and men had different patterns of postoperative complications and recovery, with age and implant strategy modifying observed differences.
In the phase 3 OPTIMA trial, the 10-mg/kg and 3-mg/kg doses reduced new heterotopic ossification lesions by 90% and 94%, respectively, compared with placebo at 56 weeks.
Achievable goals, activity tracking, and social support are among the strategies JAMA researchers recommend for patients with chronic medical conditions.
A study of more than 450,000 participants linked self-reported oral health issues with an increased risk of incident autoimmune diseases, though the investigators cautioned that the findings do not establish causality.
A study of more than 450,000 participants linked self-reported oral health issues with an increased risk of incident autoimmune diseases, though the investigators cautioned that the findings do not establish causality.
Researchers found that modifying electrostatic interactions between a model osteogenic peptide and gelatin microparticles influenced peptide loading and sustained release in an in vitro hydrogel platform.